Astec share price rallied over 6 per cent intraday on the NSE, after the company reported more than ten-fold jump in consolidated net profit at Rs 11.18 cr for the quarter ended September 30, 2016 (Q2FY17). The agrochemicals company had a loss of Rs 1.01 cr in the same quarter year ago.
Total income from operations grew over 30 per cent at Rs 90 cr during the quarter under review against Rs 62.75 cr in the corresponding quarter of previous fiscal. EBITDA or earnings before interest, taxes, depreciation, and amortization margin improved to 25.9 per cent from 14.77 per cent.
At 12:06 pm, Astec share price was up 5.64 per cent at Rs 621 on the National Stock Exchange (NSE). The trading volumes on the counter stood at 2,97,020 shares having a traded value of Rs 1843.48 lacs.
According to Dynamic Levels analysts and researchers, Astec belongs to the top 500 shares set for this quarter. The stock has both strong financials and fundamentals.
| Face Value (Rs.) | 10 |
| 52 Week High (Rs.) | 674.00 (02-Nov-16) |
| 52 Week Low (Rs.) | 170.00 (29-Feb-16) |
| Life Time high (Rs.) | 674.00 (02-Nov-16) |
| Life Time low (Rs.) | 13.85 (29-Jul-13) |
| Average Daily Movement [ADM] | 27.49 |
| Average Volume [20 days] | 86672 |
| 1 Month Return (%) | 3.64 |
| Book Value | 59.94 |
| Market Cap (as on 13th Dec 2016) | 1146.53 (Cr) |
Astec LifeSciences has a rich experience of over two decades in the chemical industry. Astec employs highly qualified and trained personnel to monitor and to maintain its manufacturing activities as well as process development work. A strong R&D focus has enabled the company to introduce many unique products. As the operations are highly integrated both horizontally and vertically, the company has a very efficient, low cost structure in the market place.
In order to know about the support and resistance levels of the scrip and also its fundamentals and financials, please a pay a visit to Astec share price history. 
No comments:
Post a Comment